3-3845266-A-G
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_020873.7(LRRN1):c.625A>G(p.Met209Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000533 in 1,614,066 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020873.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRN1 | NM_020873.7 | c.625A>G | p.Met209Val | missense_variant | Exon 2 of 2 | ENST00000319331.4 | NP_065924.3 | |
LRRN1 | NM_001324188.2 | c.625A>G | p.Met209Val | missense_variant | Exon 3 of 3 | NP_001311117.1 | ||
LRRN1 | NM_001324189.2 | c.625A>G | p.Met209Val | missense_variant | Exon 3 of 3 | NP_001311118.1 | ||
LRRN1 | XM_047448644.1 | c.625A>G | p.Met209Val | missense_variant | Exon 2 of 2 | XP_047304600.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152216Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000279 AC: 7AN: 251196 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000568 AC: 83AN: 1461850Hom.: 0 Cov.: 76 AF XY: 0.0000619 AC XY: 45AN XY: 727236 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74372 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.625A>G (p.M209V) alteration is located in exon 2 (coding exon 1) of the LRRN1 gene. This alteration results from a A to G substitution at nucleotide position 625, causing the methionine (M) at amino acid position 209 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at